Skip to content

Debt-to-assets at other companies

Merck & Co. logo
Merck & Co.MRK
0.4×+0.1×
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
0.4×+0.2×
LQD
Liquidia CorporationLQDA
0.0×

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Calculated from Trevi Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s debt-to-assets?
Trevi Therapeutics, Inc. (TRVI) reported debt-to-assets of 0× in Q1 2026.
How has Trevi Therapeutics, Inc.'s debt-to-assets changed year-over-year?
Trevi Therapeutics, Inc.'s debt-to-assets decreased by 57.3% year-over-year, from 0× to 0×.
What is the long-term trend for Trevi Therapeutics, Inc.'s debt-to-assets?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s debt-to-assets has grown at a -6.6% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.